Among all molecular alteration types in gliomas, IDH genotype is the most important, as patients with the IDH gene mutation have significantly longer survival time than patients of IDH wild-type, which is independent of WHO grade [12,13]. The gene discussed is IDH2; the disease is central nervous system cancer.